Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: CombiGene strives for a broader pipeline

In 2021, Swedish gene therapy company CombiGene signed an exclusive, global license agreement for candidate CG01 with Spark Therapeutics, which entitles CombiGene to up to 328.5 million USD excluding royalties. The parties are now putting the finishing touches on the preclinical work, after which Spark will be responsible for and pay for the first clinical studies in patients with drug-resistant focal epilepsy.Read the full article about CombiGene at biostock.se: https://www.biostock.se/en/2022/04/combigene-strives-for-a-broader-pipeline/ This is a press release from BioStock -

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 99 - 21 APRIL 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

SelectImmune Pharma releases new film about immunotherapy

Today we are proud to present a new film entitled “Immunotherapy - a complement to antibiotics’’. The film tells the story about SelectImmune Pharma’s drug development program and the scientific discoveries that have defined new and exciting tools for treating infections. SelectImmune is developing several drug candidates with exciting potential. In the film you will meet the multinational and talented research team and hear their stories about their favourite molecules and technologies. You will also meet Dr. Björn Wullt, who has used innate immunotherapy to treat patients with bladder

New Nordic Schools releases Kwizie to help teachers instantly create engaging and inspiring quizzes with AI

Kwizie instantly creates and grades quizzes from any text-based resource, giving insights into each student’s level of understanding and saving teachers endless hours.Finnish education company  New Nordic Schools  launches  Kwizie  – an online tool that helps teachers engage with their students and save endless hours by instantly creating and grading quizzes with cutting-edge Artificial Intelligence (AI).  

Reading Rewards: Readly partners with Virgin Red

                                                                                                                                                                     Fancy earning loyalty points by reading your favourite newspapers and magazines? Well now you can! Virgin Red, Virgin’s rewards club, has partnered with Readly, the digital magazine and newspaper app, to offer members up to 750 Virgin Points and their first month free when they sign-up to Readly through Virgin Red.   Readly’s  subscription service offers unlimited digital access to more

Invitation to presentation of Coor’s Q1 2022 Report on April 29, 2022

Invitation to presentation of Coor’s Q1 2022 Report on April 29, 2022.Coor Service Management will be publishing its Q1 2022 Report on April 29, at 13:00 CEST. Accordingly, we’re inviting investors, analysts and media to a webcast (in English) on April, 29, at 14:00 CEST, where Coor’s President and CEO AnnaCarin Grandin together with CFO and IR Director Klas Elmberg will present and comment on the Interim Report.   To participate in the webcast, please register in advance via the following link: https://onlinexperiences.com/Launch/QReg/ShowUUID=C6B47941-F472-4DEC-BC23-D136DC7D7AE1

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (BlackRock, Inc.)

Nordea Bank AbpStock exchange release – Major shareholder announcements21 April 2022 at 10.00 EET Nordea Bank Abp has on 20 April 2022 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has decreased below the threshold of 5 per cent on 19 April 2022. The total number of shares and voting rights in Nordea Bank Abp is 3,860,317,333. Total positions of BlackRock, Inc. and its funds according to the notification: % of %

The growth trend continues to permeate the industry

Cinodes Q4 report shows that the listed consulting companies in Sweden and Finland had an average growth of 25% in Q4, and 15% in 2021. The Swedish IT consulting companies top the list, Much due to the high number of acquisitions. The Swedish market has slightly higher growth figures compared to Finland. Swedish consulting companies report an average growth of 16.7% over the year whilst Finnish companies grew by 8.8 % on average, in 2021.Exsitec, Knowit, Prevas and Finnish Gofore were the companies with the highest growth figures in Q4.   - The growth in Q4 has broken records, and we

Crown Energy confirms receipt of payment of USD 8 million

INSIDE INFORMATION: Crown Energy AB ("Crown Energy" or the "Company") is happy to inform the market that the second instalment of USD 8 million has been credited to the Company’s account today, as per the signed agreement of 20/10/21.On 20 October 2021 Crown Energy has entered into an agreement under which the purchaser has the right to acquire (or pre-empt any sale of) Crown Energy’s up-stream oil and gas assets (except for operations in South Africa).   Crown Energy announces today that the second instalment of USD 8 million has been credited to Company’s account. This corresponds

CLS has entered agreement with Quadia Diagnostic Imaging Center in Piaseczno, Poland on commercial evaluation of TRANBERG® Thermal Therapy System in MR-guided ablation of localized prostate cancer

Clinical Laserthermia Systems AB (publ) today announced that the company has entered an agreement with Quadia Diagnostic Imaging Center in Piaseczno, Poland on a commercial evaluation of its second-generation TRANBERG® Thermal Therapy System with Thermoguide™ Workstation in MR-guided stereotactic focal laser ablation of localized prostate cancer.“We are very pleased that Quadia, a private imaging center with well-established reputation on the Polish market as the leading site in the MRI diagnostics of prostate cancer and other urological malignancies, have decided to evaluate our second-

BioStock Studio: Expres2ion’s CEO gives status update

Biotech ExpreS2ion Biotechnologies – that develops vaccines for covid-19, breast cancer, influenza and malaria – is currently conducting a rights issue of 73 million SEK. CEO Bent U. Frandsen visited BioStock’s studio to give a status update on the covid-19 project, which is being developed together with Bavarian Nordic, and to tell us more about the rights issue.Watch the interview at biostock.se: https://www.biostock.se/en/2022/04/biostock-studio-expres2ions-ceo-gives-status-update/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Invitation to presentation of Inwido´s Q1 interim report on April 28

Inwido will publish its first quarter results on April 28, 2022 at 07:45 am CET.A webcast for investors, analysts and media will be held at 10.00 (CET) that same day. The report will be presented by Henrik Hjalmarsson, President and CEO and Peter Welin, CFO. The presentation will be held in English and will also be live webcasted at:https://www.inwido.com/investors/financial-reports-and-presentations Here you will also find the presentation material for the meeting before it starts. It will also be possible to take part of the webcast afterwards at Inwido.com. Registration is not

Carbiotix hires Chief Medical Officer to support product expansion efforts

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company has hired Dr. Richard A. Rosenbloom (M.D. & Ph.D.) as its new Chief Medical Officer (CMO). Richard has been an advisor to Carbiotix since 2019 and starting in May will assist the Company with CMO duties, product development, regulatory affairs, pharmacovigilance, safety and medical affairs. Richard has decades of experience working in the United States as a CMO, Medical Director and Director of Medical Affairs for both pharmaceutical and clinical research companies. As the new CMO, Richard will support the Company’s

Today is the last day on which TO3 series CLS subscription warrants can be traded

Today, April 21, 2022, is the last day on which subscription warrants from the TO3 series (the “subscription warrants”) issued by Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) in connection with the rights issue of units and the directed issue of units carried out by the Company in April 2021 can be traded. The subscription warrants are traded on Nasdaq First North Growth Market. One (1) subscription warrant provides the right to subscribe for one (1) new class B share in CLS at a price of SEK 3.50. In the case of full exercising of all the subscription warrants, CLS will

Beijer Ref Q1 2022

"We began the year strongly with organic sales increase of 16 per cent. All of our geographical segments had positive developments and we report total sales growth of 31 per cent compared with the same period last year. Our southern hemisphere markets had a good summer season and the acquisitions in Asia Pacific (APAC) show good growth", says Christopher Norbye, CEO Beijer Ref. FIRST QUARTER · Organic sales rose 15.8 per cent in the quarter compared to the previous year. Acquisition effects were 10.0 per cent and currency effects were 5.6 per cent. Net sales increased by 31.4 per

Notice of Annual General Meeting of Implantica AG

The shareholders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby given notice of the annual general meeting on Tuesday, May 10, 2022, at 11:00.Pursuant to Act 5 from November 2021 in the context of Covid-19 (COVID-19-VJBG), accompanying measures in judicial and administrative procedures continue to be in force. Therefore, the annual general meeting on Tuesday, May 10, 2022, will be held without the physical presence of participants and personal participation of shareholders and only the statutorily required people will attend the meeting. The meeting process will include control

Idag är sista dag för handel för CLS teckningsoptioner av serie TO3

Idag, den 21 april 2022, är sista dag för handel för de teckningsoptioner av serie TO3 (”teckningsoptionerna”) som Clinical Laserthermia Systems AB (publ) (“CLS” eller “Bolaget”) emitterade i samband med den företrädesemission av units samt den riktade emissionen av units som Bolaget genomförde under april 2021. Teckningsoptionerna handlas på Nasdaq First North Growth Market. En (1) teckningsoption ger rätt att teckna en (1) ny B-aktie i CLS till en kurs om 3,50 SEK. Vid fullt utnyttjande av samtliga teckningsoptioner kommer CLS att tillföras cirka 35,6 MSEK före emissionskostnader.

Interim Management Statement 1 January-31 March 2022

CEO Dr. Martin Edlund: “With a strong confidence from our financial partners, we continue our dedicated work to demonstrate tidal energy as a commercially viable energy source.”Significant events January-March 2022 · In March, Minesto announced that the company has decided to concentrate its operational activities this year on the new, upgraded Dragon Class power plants in Vestmannasund, Faroe Islands. Within the framework of the existing electricity purchase agreement with SEV, the company's customer and partner in the Faroe Islands, the plan is to install two Dragon 4 systems in 2022,

Epiroc awards recognize smart drill rig, customer collaboration, and enhanced US operation

Stockholm, Sweden: Epiroc, a leading productivity partner for the mining and Infrastructure industries, is recognizing a next generation surface drill rig, successful cooperation with a customer in the Democratic Republic of the Congo, and the enhanced Customer Center in the United States with three annual awards.The Inspired by Innovation Award honors Epiroc’s most innovative technical development that has had a proven commercial success. It is presented to the team behind the new generation SmartROC D65 surface drill rig. The upgraded SmartROC D65 has an automation-ready platform,

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 20th April 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,669,042 shares.  Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

The Interim Amendments to Quant’s Senior Bonds become effective

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Following the approval of the written procedure initiated pursuant to a notice of written procedure dated 24 March 2022 (the “Notice”) in respect of its up to EUR 120,000,000 Senior Secured Floating Rate Bonds with ISIN: SE0010663260 (the “Senior Bonds”), Quant AB (publ) (“Quant”) is pleased to announce that the conditions precedent to the effectiveness of the Interim

Interim Management Statement January-March 2022

”The first quarter of 2022 will always be remembered for the unprovoked Russian invasion of Ukraine. The war is, first and foremost, a human tragedy, but it will most likely also have longer-term implications on geopolitics and business. We continue to work closely with our companies to support them in this unpredictable environment.”Johan Forssell, President & CEO of Investor Highlights during the first quarter ·Adjusted net asset value (NAV) amounted to SEK 684,107m (SEK 223 per share) on March 31, 2022, a change of SEK -76,855m, or -10 percent, during the quarter. Total

There are no items matching the current filter
There are no more items matching the current filter
Back to top